1. Home
  2. UFPT vs MNKD Comparison

UFPT vs MNKD Comparison

Compare UFPT & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

N/A

Current Price

$204.79

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$2.82

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UFPT
MNKD
Founded
1963
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
UFPT
MNKD
Price
$204.79
$2.82
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$289.00
$8.64
AVG Volume (30 Days)
187.1K
6.4M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
N/A
EPS
8.75
0.02
Revenue
$602,797,000.00
$348,966,000.00
Revenue This Year
$8.33
$33.40
Revenue Next Year
$5.59
$16.48
P/E Ratio
$23.93
$140.50
Revenue Growth
19.50
22.23
52 Week Low
$178.26
$2.52
52 Week High
$274.93
$6.51

Technical Indicators

Market Signals
Indicator
UFPT
MNKD
Relative Strength Index (RSI) 35.08 23.92
Support Level $188.43 N/A
Resistance Level $206.13 $6.08
Average True Range (ATR) 12.35 0.37
MACD -0.82 -0.09
Stochastic Oscillator 16.36 8.26

Price Performance

Historical Comparison
UFPT
MNKD

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: